| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3590b1ca03470e3edef9246a551602d8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2007-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9503c3837c922a5fc7edd476940e8c90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c24669a6cb39bb6eb088eb9d3f3c1c15 |
| publicationDate |
2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2642632-A1 |
| titleOfInvention |
Immunoglobulins from vitiligo plasma for melanoma therapy |
| abstract |
This invention relates to compositions and methods of treating melanoma in a subject. Specifically, the invention is directed to the use of Immunoglobulins and their functional fragments isolated from vitiligo or melanoma patients in the treatment of melanoma. |
| priorityDate |
2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |